sample taken on to blotting paper was developed. A sample of approximately 20 RI of blood was required. A high correlation and level of absolute agreement was shown between paired finger prick and venepuncture blood spots, and between blood spot, serum spot, and serum samples. Healthy controls and non-infected patients with cystic fibrosis had low titres of antibody compared with patients with intermittent and chronic infection. The latter groups had significantly greater antibody titres than normal controls. This assay permits serial measurement of antibodies to P aeruginosa in patients of all ages with cystic fibrosis and may provide a means of assessing the value of such measurements in the detection and management of early infection.
Chronic lung infection with Pseudomonas aeruginosa is the main cause of morbidity and mortality in patients with cystic fibrosis.' There may be a period of harmless colonisation of the respiratory tract before infection becomes chronic, after which the organism is never completely eradicated from the lungs. Lung injury caused by chronic infection is probably mediated by the formation of immune complexes between P aeruginosa derived antigens and host immunoglobulins. 3 Chronic P aeruginosa infection may be diagnosed by the determination of specific IgG class antibodies in serum by counterimmunoelectrophoresis or enzyme linked immunosorbent assay (ELISA).4 A specific antibody response may be detected before there is regular isolation of the organism from sputum.5 6 This early host response may also indicate the presence of lung injury,2 3but it is not clear how knowledge of an increased antibody titre should be used in the management of patients in the early stages of P aeruginosa infection.
The acquisition of P aeruginosa occurs at an early age and it is in children that the application of antibody measurements may have the greatest potential for diagnosis and early treatment to protect the lungs. Serial determination of serum antibodies in young children is, however, difficult in practice and may be unacceptable to patients and parents. To overcome this an ELISA for IgG antibody to P aeruginosa carried out on blood spot specimens from finger prick samples was developed.
Subjects and methods
Paired blood spot and serum samples were obtained by venepuncture from patients attending adult and paediatric cystic fibrosis clinics. Blood spot samples were also collected by finger prick. Data from the latter collection method are specifically indicated in the text. Adult patients with bronchiectasis and P aeruginosa infection also had samples taken. These studies were approved by the local ethics committee. Controls were drawn from healthy hospital workers and their families, and from children having blood taken for other reasons. PROCESSING -001 (fig 1) . There was a significant relationship between serum spot specimens and both serum and blood spot specimens, p<0.001 and p<0.001, respectively (n=87). The agreement between the different specimens was assessed by the determination of the mean difference (95% confidence interval) for paired specimens. For blood spot specimens compared with serum specimens (n=108) the mean difference was 2-7 (1.6 to 3.7) ELISA index units, and for the blood spot specimens compared with serum spot specimens (n=87) the mean difference was 0-05 (-0.9 to 1-8). There was no significant difference between patients with cystic fibrosis in whom P aeruginosa had never been isolated from the sputum and healthy controls not known to have been infected at any time (fig 2) . Patients with either intermittent isolation of P aeruginosa (less than four isolates in one year) or chronic infection four or more isolations in one year) had significantly greater ELISA indices than controls (p<0-0002). There was overlap, however, between the former group and both the control group and the group with cystic fibrosis who had never been infected.
Discussion
The collection of small volumes of blood on blotting paper is used in screening babies for phenylketonurial°and neonatal hypothyroidism.11 3 The same simple procedure was successful for the measurement of antibodies of the IgG class in this study and gave absolute values close to those obtained with serum samples. The blood spot system is dependent on a reliable and reproducible assay. Reported ELISAs for pseudomonas antibodies did not have the within and between assay performances of the highly developed method used here. Using the same antigen as in this study a similar ELISA gave intraplate, intra-assay, and interassay variations of 14%, 19%, and 20%, respectively.5 The assay reported here could be completed in one working day, whereas other reported assays require one or two overnight incubation periods.4 5 Blood spot samples could be stored at -20°C for up to four weeks without deterioration, which suggests that such samples may be stored for long periods in such conditions. This is supported by the stability of such specimens after being stored for up to nine months at -20°C, which was as good as for paired serum specimens in storage." Another possibility yet to be studied is that blood spot specimens will keep for short periods, in a dry form at ambient temperatures, allowing them to be taken at home and posted to the laboratory for assay. This would be an advantage in epidemiological studies or for serial monitoring.
In the assay reported here normal subjects had low but detectable antibody titres, which probably indicates a general low degree of response in normal subjects. 15 This group was not statistically different from patients with cystic fibrosis who had never grown P aeruginosa from their sputum. The patients with cystic fibrosis and intermittent growth of P aeruginosa were separated from normal controls but overlapped with both the non-infected patients with cystic fibrosis and those with chronic infection, which suggests a range of exposure and host response to P aeruginosa. These findings confirm earlier reports and indicate the validity of the blood spot ELISA system reported here.5 1 17
It is not clear how to use data about antipseudomonal antibodies in the management of early infection. It is thought that intermittent isolation of P aeruginosa occurs during a phase of harmless colonisation, and that treatment during this period may delay or halt progression to chronic infection. Vigorous antipseudomonal antibiotic treatment does protect the lungs against injury and prolongs survival in chronically infected subjects,'8 but it is unknown if early intervention would have the same effect. The harmlessness of early colonisation is an assumption that could be tested by combining the method reported here with an index of lung destruction, such as measurement of urinary desmosine concentration.'9 Such an approach would help to define the role of antibody measurements in cystic fibrosis and the value of intervention with antibiotics early in P aeruginosa infection. In previous studies serial sampling has only been carried out in small numbers of patients at infrequent intervals, or simply to illustrate the value of an individual ELISA.s 16 17 Antibodies of the IgG class to P aeruginosa can reliably be determined using finger prick samples of blood collected on to Guthrie cards. This method of collection had a high level of agreement with blood samples obtained by venepuncture, which allows the prospect of repeated sampling in babies and children with cystic fibrosis with minimum disturbance to the child or parent. Such studies may define the association of antipseudomonal antibodies and the acquisition of infection, and the value of their determination in the management of early P aeruginosa infection in children with cystic fibrosis. 
